We are analyzing https://link.springer.com/article/10.1007/s00262-008-0485-6.

Title:
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis | Cancer Immunology, Immunotherapy
Description:
A period of tumor growth precedes the clinical detection of breast cancer recurrence. We explore immune, endocrine, and behavioral parameters during this period. We conducted a phase III clinical trial in which women with surgically treated stage II/III breast cancer (N = 227) were randomized to receive a psychological intervention or assessment-only and then regularly assessed for 10 years. Patients who recurred (R, n = 48) were matched with patients remaining disease-free (DF, n = 48) on demographic and prognostic characteristics, treatment, and duration of disease-free follow-up. Data at three assessment points, occurring, on average, 17, 11, and 4 months before the recurrence was detected clinically, with equivalent time points for the disease-free group, were examined. Mixed-effects models tested for group differences in immune cell counts and function as well as endocrine and behavioral parameters. In the 17 months prior to recurrence detection, patients exhibited higher white blood cell count, neutrophil, lymphocyte, and natural killer cell counts, relative to DF patients. R patients also showed higher cortisol, worse physical functioning, fatigue, and quality of life. Follow-up analyses showed patients with local recurrences to differ from those with distant recurrence, with the former exhibiting elevated natural killer cell cytotoxicity, lymphocyte proliferative response, fatigue, pain, and emotional distress (depression, anxiety), and the latter exhibiting higher neutrophil, lymphocyte, and natural killer cell counts. Patients who would recur showed reliable biobehavioral alterations more than a year prior to their diagnosis. This novel observation may contribute to our understanding of the disease relapse processes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, article, google, scholar, pubmed, breast, cas, patients, immune, research, recurrence, andersen, clinical, cell, lymphocyte, access, analysis, prognostic, counts, natural, oncol, privacy, cookies, content, data, endocrine, behavioral, thornton, blood, publish, search, tumor, growth, intervention, fatigue, peripheral, open, inflammation, manual, springer, health, res, study, university, state, function, information, log, journal, lisa,

Topics {✒️}

granulocyte colony-stimulating factor month download article/chapter early-stage breast cancer mixed-effects models tested pro-cancerous immune microenvironment anti-cancer immunological strategies article cancer immunology primary breast cancer american cancer society patients remaining disease-free breast cancer research ohio state university cell-mediated cytotoxicity full article pdf related subjects case-control analysis early breast cancer privacy choices/manage cookies breast cancer recurrence exhibiting higher neutrophil natural cytotoxic activity operable breast cancer showed higher cortisol immune cell counts tumor growth precedes tumor growth time peripheral blood correlate columbia university press natural mechanisms protecting breast carcinoma golden-kreutz dm routine blood tests cancer clinical trials blood lymphocyte counts bmc cancer 1 national cancer institute european economic area worse physical functioning check access industrial testing service soft tissue sarcomas cytokine serum levels reduced mitogenic stimulation hae-chung yang instant access analyses showed patients rectal cancer patients disease relapse processes peripheral-blood lymphocytes conditions privacy policy

Questions {❓}

Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow?
Colozza M, Azambuja E, Cardoso F et al (2005) Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Demicheli R, Terenziani M, Bonadonna G (1998) Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis
         description:A period of tumor growth precedes the clinical detection of breast cancer recurrence. We explore immune, endocrine, and behavioral parameters during this period. We conducted a phase III clinical trial in which women with surgically treated stage II/III breast cancer (N = 227) were randomized to receive a psychological intervention or assessment-only and then regularly assessed for 10 years. Patients who recurred (R, n = 48) were matched with patients remaining disease-free (DF, n = 48) on demographic and prognostic characteristics, treatment, and duration of disease-free follow-up. Data at three assessment points, occurring, on average, 17, 11, and 4 months before the recurrence was detected clinically, with equivalent time points for the disease-free group, were examined. Mixed-effects models tested for group differences in immune cell counts and function as well as endocrine and behavioral parameters. In the 17 months prior to recurrence detection, patients exhibited higher white blood cell count, neutrophil, lymphocyte, and natural killer cell counts, relative to DF patients. R patients also showed higher cortisol, worse physical functioning, fatigue, and quality of life. Follow-up analyses showed patients with local recurrences to differ from those with distant recurrence, with the former exhibiting elevated natural killer cell cytotoxicity, lymphocyte proliferative response, fatigue, pain, and emotional distress (depression, anxiety), and the latter exhibiting higher neutrophil, lymphocyte, and natural killer cell counts. Patients who would recur showed reliable biobehavioral alterations more than a year prior to their diagnosis. This novel observation may contribute to our understanding of the disease relapse processes.
         datePublished:2008-03-08T00:00:00Z
         dateModified:2008-03-08T00:00:00Z
         pageStart:1471
         pageEnd:1481
         sameAs:https://doi.org/10.1007/s00262-008-0485-6
         keywords:
            Breast neoplasms
            Neoplasm metastasis
            Leukocytes
            Granulocytes
            Fatigue
            Inflammation
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-008-0485-6/MediaObjects/262_2008_485_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-008-0485-6/MediaObjects/262_2008_485_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-008-0485-6/MediaObjects/262_2008_485_Fig3_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:57
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lisa M. Thornton
               affiliation:
                     name:Ohio State University
                     address:
                        name:Department of Psychology, Ohio State University, Columbus, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Barbara L. Andersen
               affiliation:
                     name:Ohio State University
                     address:
                        name:Department of Psychology, Ohio State University, Columbus, USA
                        type:PostalAddress
                     type:Organization
                     name:Ohio State University
                     address:
                        name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:William E. Carson
               affiliation:
                     name:Ohio State University
                     address:
                        name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis
      description:A period of tumor growth precedes the clinical detection of breast cancer recurrence. We explore immune, endocrine, and behavioral parameters during this period. We conducted a phase III clinical trial in which women with surgically treated stage II/III breast cancer (N = 227) were randomized to receive a psychological intervention or assessment-only and then regularly assessed for 10 years. Patients who recurred (R, n = 48) were matched with patients remaining disease-free (DF, n = 48) on demographic and prognostic characteristics, treatment, and duration of disease-free follow-up. Data at three assessment points, occurring, on average, 17, 11, and 4 months before the recurrence was detected clinically, with equivalent time points for the disease-free group, were examined. Mixed-effects models tested for group differences in immune cell counts and function as well as endocrine and behavioral parameters. In the 17 months prior to recurrence detection, patients exhibited higher white blood cell count, neutrophil, lymphocyte, and natural killer cell counts, relative to DF patients. R patients also showed higher cortisol, worse physical functioning, fatigue, and quality of life. Follow-up analyses showed patients with local recurrences to differ from those with distant recurrence, with the former exhibiting elevated natural killer cell cytotoxicity, lymphocyte proliferative response, fatigue, pain, and emotional distress (depression, anxiety), and the latter exhibiting higher neutrophil, lymphocyte, and natural killer cell counts. Patients who would recur showed reliable biobehavioral alterations more than a year prior to their diagnosis. This novel observation may contribute to our understanding of the disease relapse processes.
      datePublished:2008-03-08T00:00:00Z
      dateModified:2008-03-08T00:00:00Z
      pageStart:1471
      pageEnd:1481
      sameAs:https://doi.org/10.1007/s00262-008-0485-6
      keywords:
         Breast neoplasms
         Neoplasm metastasis
         Leukocytes
         Granulocytes
         Fatigue
         Inflammation
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-008-0485-6/MediaObjects/262_2008_485_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-008-0485-6/MediaObjects/262_2008_485_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-008-0485-6/MediaObjects/262_2008_485_Fig3_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:57
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lisa M. Thornton
            affiliation:
                  name:Ohio State University
                  address:
                     name:Department of Psychology, Ohio State University, Columbus, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Barbara L. Andersen
            affiliation:
                  name:Ohio State University
                  address:
                     name:Department of Psychology, Ohio State University, Columbus, USA
                     type:PostalAddress
                  type:Organization
                  name:Ohio State University
                  address:
                     name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:William E. Carson
            affiliation:
                  name:Ohio State University
                  address:
                     name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:57
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ohio State University
      address:
         name:Department of Psychology, Ohio State University, Columbus, USA
         type:PostalAddress
      name:Ohio State University
      address:
         name:Department of Psychology, Ohio State University, Columbus, USA
         type:PostalAddress
      name:Ohio State University
      address:
         name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
         type:PostalAddress
      name:Ohio State University
      address:
         name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lisa M. Thornton
      affiliation:
            name:Ohio State University
            address:
               name:Department of Psychology, Ohio State University, Columbus, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Barbara L. Andersen
      affiliation:
            name:Ohio State University
            address:
               name:Department of Psychology, Ohio State University, Columbus, USA
               type:PostalAddress
            type:Organization
            name:Ohio State University
            address:
               name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
               type:PostalAddress
            type:Organization
      name:William E. Carson
      affiliation:
            name:Ohio State University
            address:
               name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Psychology, Ohio State University, Columbus, USA
      name:Department of Psychology, Ohio State University, Columbus, USA
      name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
      name:Comprehensive Cancer Center, Ohio State University, Columbus, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(113)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.94s.

LINK . SPRINGER . COM {}